Detalles de la búsqueda
1.
Diagnostic performance of additional imaging tests for staging purposes in a bicentric German series of low-risk early breast cancer patients.
Arch Gynecol Obstet;
309(4): 1475-1481, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676317
2.
Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial.
Breast Cancer Res Treat;
202(1): 67-72, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37556015
3.
Return of individual genomic research results within the PRAEGNANT multicenter registry study.
Breast Cancer Res Treat;
197(2): 355-368, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36409394
4.
Evolving trends in the surgical therapy of patients with endometrial cancer in Germany: analysis of a nationwide registry with special emphasis on perioperative outcomes.
Arch Gynecol Obstet;
308(5): 1635-1640, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37395751
5.
The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers.
Int J Mol Sci;
24(22)2023 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38003555
6.
Early dissemination seeds metastasis in breast cancer.
Nature;
540(7634): 552-558, 2016 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27974799
7.
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.
Br J Cancer;
123(5): 793-802, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32555365
8.
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany.
BMC Cancer;
20(1): 1091, 2020 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33176725
9.
Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study.
Gynecol Oncol;
159(2): 434-441, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32919778
10.
Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial.
Int J Cancer;
144(4): 877-885, 2019 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29992557
11.
Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis.
Br J Cancer;
120(3): 301-305, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30655614
12.
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis.
Breast Cancer Res Treat;
173(2): 319-328, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30324275
13.
Correction: TERT promoter mutation in adult granulosa cell tumor of the ovary.
Mod Pathol;
32(4): 593, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29968850
14.
An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study.
J Med Internet Res;
21(1): e10004, 2019 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30668517
15.
Uterine Fibroids - Current Trends and Strategies.
Surg Technol Int;
34: 257-263, 2019 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30888674
16.
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile.
Br J Cancer;
119(4): 480-486, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30050154
17.
A high-risk 70-gene signature is not associated with the detection of tumor cell dissemination to the bone marrow.
Breast Cancer Res Treat;
169(2): 305-309, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29374853
18.
TERT promoter mutation in adult granulosa cell tumor of the ovary.
Mod Pathol;
31(7): 1107-1115, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449679
19.
Simultaneous detection of circulating and disseminated tumor cells in primary breast cancer patients following neoadjuvant chemotherapy.
Arch Gynecol Obstet;
297(3): 785-790, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29380106
20.
Female genital tract congenital malformations and the applicability of the ESHRE/ESGE classification: a systematic retrospective analysis of 920 patients.
Arch Gynecol Obstet;
297(6): 1473-1481, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29549434